After the success of first, human trials of second Russian corona vaccine to start
After the success of first, human trials of second Russian corona vaccine to start
Share:

Moscow: Russia has now started making the second corona vaccine after the success of the first possible corona vaccine trial. On Friday, the news agency cited Russia's consumer safety monitoring as saying that Russia's second possible corona infection vaccine developed by the Siberian Vector Institute could be tested on humans which will be started from 27 July.

According to the information received, the initial phase of the human trial of a vaccine developed by the Gemaleya Institute in Moscow was completed this month. And this trial was a complete success. Russia has announced in the past that it has successfully completed the human trial towards making the Corona vaccine. Russian scientists have expressed happiness over the result of this vaccine. Russian authorities have started planning this mass production of this vaccine.

Russia has stated that it has planned to produce 30 million doses of the experimental corona vaccine domestically this year, which has the capacity to manufacture one crore 70 million doses abroad. This time around the world, there is a competition for making Corona vaccine. Many countries including Britain, China, America and India are currently in different stages of human trials of the Corona vaccine. But Russia has reached ahead in this race as compared to other countries.

Also Read:

4 lakh 21 thousand coronavirus cases reported in South Africa

Corona rising rapidly in Pakistan, figures increased in 24 hours

Tropical cyclone warning issued in Texas

26/11 Mumbai attack accused Tahawwur Rana's bail plea rejected in US court

 

Join NewsTrack Whatsapp group
Related News